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ABSTRACT 
Latest developments in the technology have promoted viable dosage alternatives through oral route for pediatrics, bed ridden,  
and nauseous patients. Patient preference is one of the most important aspects in pharmacy practice. Now a day’s pharmacy 
companies are coming up with innovative drug delivery systems to deliver the drugs efficiently and with less side effects. This 
innovation led to the introduction of the concept of fast dissolving tablets. Though, a wide range of superdisintegrant is 
available for formulation of fast dissolving tablets. Still there is continuous need of development of superdisintegrants. 
Therefore in the present investigation, starch based superdisintegrant was prepared and evaluated for its application in the 
design of fast dissolving dosage forms. 
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INTRODUCTION: 
Fast dissolving tablets are solid dosage forms containing 
medicinal substances which disintegrate rapidly, usually 
within few seconds when placed upon tongue requiring no 
additional water, to facilitate swallowing. Various 
techniques can be used to formulate fast dissolving tablets. 
Direct compression method, one of most oldest and 
convenient method of formulating tablets. Direct 
compression method needs only the cheaper excipients. 
Therefore the dosage forms which were formulated by 
direct compression method will be cheaper than the dosage 
forms formulated by other methods. The aim of the work 
was to formulate and evaluate fast dissolving tablets of 
mefenamic acid employing modified starch as a 
superdisintegrant for rapid dissolution and absorption of 
drugs, which may produce the drug rapid onset of action.  
Optimization technique 
Optimization techniques provide both a depth of 
understanding and an ability to explore and define ranges 
for formulation and processing factors with a rational 
approach to for the selection of several experimental and 
manufacturing steps for a given product. 
 The present study deals with the investigation for 
optimization of mefenamic acid fast dissolving tablets 
employing modified starch, crosscarmellose sodium and 
crospovidone as superdisintegrants. A 23factorial design was 
applied to investigate the main and interaction effects of the 
three formulation variables that is, modified starch, 
crosscarmellose sodium (B) and crospovidone (C) in each 
case to find the formulation with less disintegration time and 
more dissolution efficiency 1 min and permit and arbitrary 
detection of tablets with immediate release of drug within 
five minutes. The resulting of formulation, optimization and 
evaluation of mefenamic acid is fast dissolving is described 
in this chapter.   
MATERIALS & METHODS 
1. Mefenamic acid (Yarrow chemicals, Mumbai) 
2. Modified starch prepared in the laboratory used. 
3. Crosscarmellose sodium (Yarrow chemicals, Mumbai) 
4. Crospovidone(Yarrow chemicals, Mumbai) 
5. Mannitol ( Yarrow chemicals, Mumbai) 
6. Microcrystalline cellulose (Qualigens fine chemicals, 
Mumbai) 
7. Talc (Molychem, Mumbai) 
8. Magnesium stearate  (Molychem, Mumbai) 
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Preparation of modified starch acid:  
Initially10 grams of glutaric acid was dissolved in distilled 
water and the pH was adjusted to 3.5 using 10M sodium 
hydroxide and finally made up to 25 ml. To the above 
mixture 25 grams potato starch was added and conditioned 
for 16 hrs at room temperature, later the product was kept 
in oven at 600C for 6 hrs, the mass was washed to remove un 
reacted glutaric acid. After washing the product was dried at 
600C. The product obtained was ground and sieved (# 100). 
Preparation of Mefenamic acid Fast Dissolving Tablets: 
The tablets were prepared by direct compression method. 
The composition of formulations of mefenamic acid fast 
dissolving tablets is shown in table no 1. For uniformity in 
particle size each ingredient was passed through # 100 mesh 
sized screen before mixing. Modified starch, croscarmellose 
sodium, crospovidone, mannitol, microcrystalline cellulose, 
were accurately weighed and mixed using motor and pestle, 
and then added to Mefenamic acid. Finally talc and 
magnesium stearate were added to the powder. Finally 
mixed blend was compressed by using eight station rotator 
press (Shakthi Machinineries Pvt. Ltd., Ahmadabad).  
Evaluation of Mefenamic acid Fast Dissolving Tablets:  
Hardness: [1] 
The tablet hardness which is the force required to break a 
tablet in a diametric compression force. The hardness tester 
used in the study was Monsanto hardness tester, which 
applies force to the tablet diametrically with the help of an 
inbuilt spring and expressed in kg/cm2. 
Uniformity of Weight: [1] 
Weight variation test was done with 20 tablets. It is the 
individual variation of tablet weight form the average weight 
of 20 tablets. 
Average weight of tablet % Deviations 
80 mg or less ±10 
More than 80 mg or less than 
250 mg 
±7.5 
More than 250 mg ± 5 
 
Friability[1]: 
The friability of tablets was measured using a Roche 
friabilator. Tablets were rotated at 25 rpm for 4 minutes or u 
to 100 revolutions. The tablets were then reweighed after 
removal of fines and the percentage of weight of weight loss 
was calculated.         
          –        
          
      
Content Uniformity: [2] 
For content uniformity test, ten tablets were weighed and 
powdered. A quantity  of  powder equivalent to 100 mg of 
mefenamic acid was extracted into tris buffer and filtered. 
The Mefenamic acid content was determined by measuring 
the absorbance spectrophotometrically at 256 nm after 
appropriate dilution with tris buffer. The drug content was 
calculated using the standard calibration curve. The mean 
percentage drug content was calculated as an average of 
three determinations.  
Wetting Time: [3]. 
The wetting time of the tablet was noted as the time taken 
by when the water to reache the upper surface of the tablet, 
when the tablet is placed in water. The wetting time of the 
tablets was measured using a very simple process. Five 
circular tissue papers were placed in a petridish with a 10 
cm diameter. Ten milliliters of water containing soluble dye 
(Amaranth) was added to the petridish and a fast dissolving 
tablet was carefully placed on the surface of paper. The time 
taken by to tablet to become red is noted as wetting time. 
Water Absorption Ratio: [4]. 
Initially the fast dissolving tablet was weighed. Then tablet 
was put on the tissue paper which was folded twice a small 
petridish a containing 6 ml of water, and allowed to wet 
completely. The wetted tablet was then weighted. Water 
absorption ration, R was determined using following 
equation. 
    
          
  
 
Where    W1 = weight of tablet after water absorption 
W2 = weight of tablet before water absorption  
In vitro Disintegration Time: [5]. 
Disintegration time for FDTs was determined using USP 
disintegration apparatus with tris buffer. The volume of 
medium was 900 ml and temperature was 37±0.20C. The 
time in seconds taken for complete disintegration of the 
tablet with no palatable mass remaining in the apparatus 
was measured. 
In Vitro Dissolution Rate Studies: [5]. 
The in vitro dissolution rate study of mefenamic acid fast 
dissolving tablets was performed using 8 station dissolution 
test apparatus (Electro lab TDT- 08L) fitted with paddles (50 
RPM) at 37 ± 0.50 C, using tris buffer (900 ml) as a 
dissolution media. At the predetermined time intervals 5 ml 
sample was withdrawn, filtered through 0.45 µ membrane 
filter, diluted and assayed at 256 nm using a Analytical 
technology Elico SL191 UV/Visible Double beam 
spectrophotometer. Cumulative percentage drug release was 
calculated using standard absorbance from the calibration 
curve. All the dissolution experiments were conducted in 
triplicate (n=3).  
Optimization: 
The percentages of modified starch (A), croscarmellose 
sodium (B) and crospovidone (C) were selected as 
independent variables. The dissolution efficiency in 5 
minutes was selected as dependent variable. The resulting 
data was fitted into Stat Ease, Inc. (Minneapolis, MN) Design 
Expert 11 Version software and analyzed statistically using 
analysis of Variance (ANOVA). The data were also subjected 
to 3-D response surface methodology to determine the 
influence of modified starch, croscarmellose sodium, 
crospovidone and interactions between them on dependent 
variable. 
Comparison of Optimized formula with the Marketed 
Sample: 
The optimized formula will be compared with the marketed 
formula for all its physical properties and dissolution 
parameters. The marketed sample available in the local 
market was 
Mefenamic acid 250 Mg ( MEFTAL -250) 
B.NO. HMT1628                
MFG. 10/16  Exp. 07/2020 of all taxes BLUE CROSS  (Made 
in India) Laboratories Pvt.LTD. L17 Verna Industries, Estate 
verna, Ram nagar (dist) Goa .
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Table 1: Formulation of Mefenamic acid Fast Dissolving Tablets Employing Modified starch 
Ingredients 
(mg/tablet) 
F1 F2 F3 F4 F5 F6 F7 F8 
Mefenamic acid 200 200 200 200 200 200 200 200 
Modified starch - 25 - 25 - 25 - 25 
Croscarmellose sodium - - 25 25 - - 25 25 
Crospovidone - - - - 25 25 25 25 
Mannitol 80 55 55 30 55 30 30 5 
Micro crystalline cellulose 200 200 200 200 200 200 200 200 
Talc 10 10 10 10 10 10 10 10 
Magnesium stearate 10 10 10 10 10 10 10 10 
Total weight 500 500 500 500 500 500 500 500 
 
Table 2: Physical properties: Hardness, Friability, Drug Content, Wetting Time, Water Absorption Ratio of Mefenamic 
acid Fast Dissolving Tablets. 
Formul-
ation 
code 
Hardness 
(Kg/Cm2) 
±S.D 
Friability 
(%)±S.D 
Drug 
Content±S.D 
Disintegration 
Time (S)±S.D 
Wetting 
Time 
(sec)±S.D 
Water 
Absorption 
Ratio(%)±S.D 
F1 3.8±0.01 0.13±0.015 197.58±0.17 3620±0.3 256±0.5 0.18±0.2 
F2 3.7±0.03 0.14±0.013 198.12±0.79 25±0.6 19±0.22 1.54±0.14 
F3 3.7±0.02 0.12±0.014 195.61±0.63 160±0.03 350 ±0.39 0.41±0.13 
F4 3.7±0.04 0.14±0.014 198.56±0.36 142±0.01 280±0.21 0.12±0.12 
F5 3.7±0.01 0.13±0.013 199.83±0.56 35±0.02 125±0.01 0.74±0.11 
F6 3.7±0.03 0.14±0.012 199.34±0.18 40±0.05 57±0.19 0.92±0.13 
F7 3.8±0.04 0.12±0.013 199.56±0.57 30±0.04 26±0.13 1.14±0.12 
F8 3.9±0.03 0.15±0.014 99.27±0.11 41±  0.01 39±0.02 1.08±0.23 
*SD standard deviation from mean, n=3, mean±SD. 
 
F1 Mefenamic acid Fast Dissolving Tablets 
 
 
At T=0 sec At T=256 sec 
F2 Mefenamic acid Fast Dissolving Tablets 
 
 
At T=0 sec                                                             At T=19 sec                        
Fig: 1(a) Wetting Times of Mefenamic acid Fast Dissolving Tablets Employing Modified starch (A Novel 
Superdisintegrant) 
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F3 Mefenamic acid Fast Dissolving Tablets 
 
  
At T=0 sec At T=350 sec                
F4 Mefenamic acid Fast Dissolving Tablets 
 
 
At T=0sec                                                                 At T=280 sec                  
F5 Mefenamic acid Fast Dissolving Tablets 
  
At T=0 sec At T=125 sec 
F6 Mefenamic acid Fast Dissolving Tablets 
  
At T=0 sec                                                             At T=57 sec                        
F7 Mefenamic acid Fast Dissolving Tablets 
  
At T=0 sec At T=26 sec                
F8 Mefenamic acid Fast Dissolving Tablets 
  
At T=0 sec                                                                 At T=39sec                  
Fig: 1(b) Wetting Times of Mefenamic acid Fast Dissolving Tablets Employing Modified starch (A Novel 
Superdisintegrant) 
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Table: 3. Dissolution Data of Mefenamic acid Fast Dissolving Tablets Employing Modified starch 
Mefenamic acid Percent Dissolved from Fast Dissolving Tablets Employing Modified starch 
Time 
(Min) 
F1 F2 F3 F4 F5 F6 F7 F8 
5 4.4±0.74 89.12±0.74 57.16±0.8 68.40±0.82 69.96±0.21 54.87±0.75 42.57±0.43 77.20±0.36 
10 13.43±0.78 99.94±0.41 83.55±0.99 99.84±0.84 95.79±0.12 60.11±0.09 63.24±0.52 83.87±0.27 
15 25.26±0.38 - 83.49±0.16 - 99.36±0.63 64.57±0.12 94.32±0.18 99.56±0.14 
30 30.89±0.32 - 93.65±0.09 - _ 85.29±0.32 96.64±0.23 - 
45 31.69±0.15 - 97.07±0.21 - _ 99.40±0.16 99.31±0.56 - 
60 33.83±0.24 - _ - _ _ _ - 
*SD standard deviation from mean, n=3, mean±SD. 
 
Fig. 2: Dissolution Profiles of Mefenamic acid Fast 
Dissolving Tablets Employing Modified starch (F1 to F4) 
 
 
Fig. 3: Dissolution Profiles of Mefenamic acid Fast 
Dissolving Tablets Employing Modified starch (F5 to F8) 
 
Fig 4: Log Time Vs Log Percent Undissolved Mefenamic 
acid Fast Dissolving Tablets Employing Modified starch 
(F1 to F4) 
 
Fig 5: Log Time Vs Log Percent Undissolved Mefenamic 
acid Fast Dissolving Tablets Employing Modified starch 
(F5 to F8) 
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 Table 4: Dissolution Parameters of Mefenamic acid Fast Dissolving Tablets Formulated Employing Modified starch  
Parameters F1 F2 F3 F4 F5 F6 F7 F8 
PD5 4.4±0.74 89.12±0.74 57.16±0.8 68.40±0.82 69.96±0.21 54.87±0.75 42.57±0.43 77.20±0.36 
DE5 (%) 3±0.1 88.1±0.2 55.6±0.3 65.1±0.1 62.5±0.2 52.5±0.3 73.2±0.2 76.13±0.2 
Increase in DE5 
(%) No. of folds 
- 29.36 18.53 21.7 20.83 17.5 24.4 25.37 
K1 (min-1) 0.01±0.01 0.3915±0.03 0.184±0.003 0.322±0.01 0.414±0.01 0.045±0.02 0.01±0.01 0.09±0.02 
Increase in K1 
(min-1) No. of 
folds 
- 39.15 39.15 53.6 237.8 184.2 127.8 92.1 
*SD standard deviation from mean, n=3, mean±SD, PD5-Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 min., K1 
=First order rate constant 
 
RESULTS AND DISCUSSION 
Fast dissolving tablets each containing 200 mg of mefenamic 
acid could be prepared by employing modified starch and 
other known superdisintegrants, croscarmellose sodium and 
crospovidone by direct compression method. Hardness of 
the tablets was in range of 3.7-3.9kg/sq.cm. It indicates good 
strength with a capability to resist physical and 
prefunctionary stress condition during handling. Weight loss 
on the friability test was less than 0.16% in all cases. All the 
fast dissolving tablets prepared containing mefenamic acid 
with in 100±5% of the labeled claim. As such the prepared 
tablets were of good quality with respect to drug content, 
hardness and friability. The disintegration time of all 
formulated tablets was found to be in the range of 25±0.6 to 
3620±0.3 seconds as indicated in the table: 2. The F2 
formulation containing 5% novel superdisintegrant i.e. 
modified starch disintegrated rapidly. 
The results in-vitro wetting time and water absorption ratio 
were found to be within prescribed limits and satisfy the 
criteria of fast dissolving tablets (Fig.5). The in-vitro wetting 
time was decreased when the novel superdisintegrant was 
used. In the case of formulation F2 modified starch, the 
wetting item found to be 19±0.22sec, indicating the 
suitability of modified starch as novel superdisintegrant.  
To evaluate the individual and combined effects of the 
factors involved, fast dissolving tablets were formulated 
employing selected combination of the factors as per 23- 
factorial design. The disintegration wetting time and release 
parameters (percent drug dissolved in 10 min and 
dissolution efficiency in 5 min) of the fast dissolving tablets 
formulated were analyzed as per ANOVA of 23- factorial 
design indicated that the individual, effects of modified 
starch (A), croscarmellose sodium (B), and crospovidone (C) 
as well as the combined effect of AB, AC, BC and (ABC) 
factors were significant on all the parameters analyzed. 
Within 25±0.6seconds indicating the suitability of modified 
starch as superdisintegrants.  
 
 
TABLE-5 ANOVA of Disintegration Time of Mefenamic acid Fast Dissolving Tablets 
 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance
Source of  
Variation 
d. f S.S M.S.S Variance 
ratio 
Result 
W 2 6968.62 3484.31 0.013        
Treatments 7 33832688.67 4833241.23 19.15        
Modified starch(A) 1 1228085.04 1228085.04 4.86        
Croscarmellose sodium (B) 1 10159509.38 10159509.38 40.21        
Modified starch x Croscarmellose 
sodium (AB) 
1 1248984.37 1248984.37 4.95        
Crospovidone (C) 1 5541126 5541126 21.96        
Modified starch x Crospovidone 
(AC) 
1 1259042.04 1259042.04 4.98        
Croscarmellose sodium  x 
crospovidone (BC) 
1 10159509.38 10159509.38 40.26        
Modified starch x Croscarmellose 
sodium x Crospovidone (ABC) 
1 1248984.37 1248984.37 4.9        
Error 14 3532408.29 252314.87 --- --- 
Total 23 30307249 1619.25 --- --- 
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TABLE-6 ANOVA of Water Absorption Ratio of Mefenamic acid Fast Dissolving Tablets 
Source  of 
 Variation 
d. f S.S M.S.S Variance 
ratio 
Result 
Replicates 2 18.08 9.0416 0.3677261        
Treatments 7 363582.291 51940.327 2112.400        
Modified starch(A) 1 55392.041 55392.041 2252.78        
Croscarmellose sodium (B) 1 83662.041 83662.041 3402.51        
Modified starch x Croscarmellose sodium 
(AB) 
1 17985.37 17985.37 731.46        
Crospovidone (C) 1 161868.37 161868.37 6583.22        
Modified starch x  
Crospovidone (AC) 
1 18872.041 18872.041 767.5305        
Croscarmellose sodium x Crospovidone 
(BC) 
1 21182.041 21182.041 882.58        
Modified starch x Croscarmellose sodium x 
Crospovidone (ABC) 
1 4620.375 4620.375 192.51        
Error 14 24.5883 1.756307 --- --- 
Total 23 363624.9583 15809.7808 --- --- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
TABLE-7 ANOVA of Percent Drug Dissolved in 5 Minutes of Mefenamic acid Fast Dissolving Tablets 
Source of  
Variation 
d. f S.S M.S.S Variance 
ratio 
Result 
Replicates 2 46.47 23.23 10.70        
Treatments 7 13172.73 1881.8 867.18        
Modified starch (A) 1 20047.93 20047.93 9238.6        
Croscarmellose sodium (B) 1 233.68 233.68 107.68        
Modified starch x Croscarmellose sodium  (AB) 
 
1 3465.84 3465.84 1597.18        
Crospovidone (C) 1 308.81 308.81 142.30        
Modified starch x Crospovidone (AC) 1 13792.81 13792.81 6356.13        
Croscarmellose sodium x Crospovidone (BC) 1 470.90 470.90 217.00        
Modified starch x Croscarmellose sodium x 
Crospovidone (ABC) 
1 0.73 0.73 0.33        
Error 14 30.44 2.17 --- --- 
Total 23 13249.64 576.07 --- --- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance 
 
TABLE-8 ANOVA of Drug Dissolution Efficiency in 5 Min Mefenamic acid Fast Dissolving Tablets 
Source of variation d. f S.S M.S.S Variance 
ratio 
Result 
Replicates 2 44.56 22.28 10.9        
Treatments 7 19102.38 2728.9 1344.28        
Modified starch (A) 1 181.5 181.5 89.40        
Croscarmellose sodium (B) 1 8588.16 8588.16 4230.62        
Modified starch x Croscarmellose sodium 
(AB) 
1 185.92 185.92 91.58        
Crospovidone (C) 1 7833.76 7833.76 3858.99        
Modified starch x  Crospovidone (AC) 1 181.5 181.5 89.40        
Croscarmellose sodium x Crospovidone (BC) 1 2308.88 2308.88 1137.37        
Modified starch x Croscarmellose sodium x 
Crospovidone (ABC) 
1 2.80 2.80 1.03        
Error 14 28.55 2.03 --- --- 
Total 23 19175.49 833.71 --- --- 
*SD Standard Deviation from mean, n=3, P<0.05 indicate significance; P>0.05 indicate non-significance, d. f–Degree of Freedom 
*S. S–Sum of Square *M. S. S–Mean Sum of Squares, ANOVA= Analysis of Variance
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ANOVA of disintegration time, wetting time, percent drug 
dissolved and dissolution efficiency in 5 min  (Table:5,6,7 
and8) indicated that the individual effect as well as combined 
effects of the three factors (i.e. modified starch, 
croscarmellose sodium and crospovidone) were all 
significant (p<0.05). The ANOVA results, thus indicated that 
the three factors have significantly influence the 
disintegration time, wetting time, percent dissolved in 10 
min and dissolution efficiency in 5min. 
Mefenamic acid fast dissolving tablets (F2) formulated 
employing modified starch (5%), as novel superdisintegrant 
exhibited good disintegration and dissolution efficiency in 5 
min. Formulation F2 gave release of 99.89±12% in 10 min 
fulfilling the official specification, based on disintegration on 
time and dissolution efficiency in 5 min,. F2 is considered as 
a good fast dissolving tablet formulation of mefenamic acid. 
A polynomial regression algorithm was used to relate the 
independent variables to the response variables. The general 
second order model equation that could be constructed from 
2n experimental design is in indicated in equation (1). 
Y= β0 + β1A + β2B + β3C + β1β2 AB + β1 β3 AC + β2β3 BC + β1β2 
β3 ABC ---- Eq(1). 
Where Y is the measured response, β0 is the arithmetic mean 
response of 8 runs , β1, β2, β3, β1β2, β1 β3, β2β3, β1β2 β3 are the 
coefficients for the corresponding factors, and A, B, C, AB, AC, 
BC and ABC are the percentages of modified starch (A) ,  
croscarmellose sodium (B) and crospovidone (C) and 
interaction terms respectively. The co-efficients were 
calculated according to the general formula given in equation  
27. 
β = Σ XY/2n                                                 ----Eq (2) 
where β is the coefficient, X is the corresponding variable 
(A,B,C) and Y is the response value (dissolution efficiency in 
5 minutes) and n is the level. 
The two levels of the three factors employed in the 
experimental design are indicated in Table 9 and 
transformed design for analysis of responses of mefenamic 
acid fast dissolving tablets is shown in Table 10. 
 
Table 9: Levels of the three factors used in the experimental design 
Factors Levels 
Ingredient Code L1 L2 
Modified Starch A 0 5 
Croscarmellose sodium B 0 5 
Crospovidone C 0 5 
 
Table 10: Transformed design for analysis of responses of Mefenamic acid Fast Dissolving Tablets 
Formula code A (%) B (%) C (%) 
F1 0 0 0 
F2 5 0 0 
F3 0 5 0 
F4 5 5 0 
F5 0 0 5 
F6 5 0 5 
F7 0 0 5 
F8 5 5 5 
 
The dissolution efficiency in 5 minutes, dissolution data 
clearly indicate that the dependent variables are strongly 
dependent on the independent variables. The fitted 
equations relating the response dissolution efficiency in 5 
minutes to the transformed factor are shown in equations 3 
& 4. 
Final Equation in Terms of Coded Factors: 
Dissolution efficiency in 5 minutes = 
+59.52+10.94A+7.99B+6.57C-7.83AB-12.71AC+ 
0.5913BC+11.07ABC (R2 = 1.000)                               ---Eq (3) 
The value of the R2 indicates a good fit. The polynomial 
equations can be used to draw a conclusion after considering 
the magnitude of coefficient and the mathematical sign it 
carries (positive or negative). 
From the polynomial equations, one can easily deduce that 
the effect of interactions between modified starch and 
croscarmellose sodium (AB) ; modified starch and 
crospovidone (AC); croscarmellose sodium and 
crospovidone (BC) are significant on the  dissolution 
efficiency in 5 minutes. On the contrary, the magnitudes of 
coefficients of modified starch (A), croscarmellose sodium 
(B), crospovidone (C) and interaction between modified 
starch, croscarmellose sodium and crospovidone (ABC) are 
larger and positive, showing that the  dissolution efficiency in 
5 minutes of mefenamic acid fast dissolving tablets is 
affected by all A, B, C and ABC. The equation for dissolution 
efficiency in 5 minutes suggests that the factor A has more 
significant effect on dissolution efficiency in 5 minutes 
followed by factor B, C and interaction term ABC. 
Once, the polynomial equation which relates the levels of 
each factor and their corresponding interactions with 
dissolution efficiency in 5 minutes was derived, the surface 
response curves and contour plots were constructed using 
Stat Ease, Inc. (Minneapolis, MN) Design Expert  11 Version 
software. 
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(A) Response Surface Plot 
 
(B) Contour Plot 
Fig.6: (A) Response Surface Plot (B) Contour Plot of Mefenamic acid Fast dissolving tablets. (effect of Modified 
starch and Croscarmellose sodium on Dissolution efficiency in 5 minutes). 
 
(A) Response Surface Plot 
 
(B) Contour Plot 
Fig.7: (A) Response Surface Plot (B) Contour Plot of Mefenamic acid Fast dissolving tablets. (effect of Modified starch 
and Crospovidone on Dissolution efficiency in 5 minutes). 
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(A) Response Surface Plot 
 
(B) Contour Plot 
(C) Fig.8: (A) Response Surface Plot (B) Contour Plot of Mefenamic acid Fast dissolving tablets. (effect of 
Crospovidone and Croscarmellose sodium on Dissolution efficiency in 5 minutes) 
 
The response surface plots and contour plots reveal that as 
the concentration of modified starch (A) increases, 
dissolution efficiency in 5 minutes increases. The other two 
variables also croscarmellose sodium (B) and crospovidone 
(C) have a positive effect on dissolution efficiency in 5 
minutes i.e., as the concentrations of B and C increases, 
dissolution efficiency in 5 minutes also increases. The effects 
of A and B on dissolution efficiency in 5 minutes are shown 
in Fig 6. The contour plots were found to be almost linear 
indicating a linear relationship between A and B on 
dissolution efficiency in 5 minutes. It was determined from 
the contour plot (Fig 6 B), that a higher dissolution efficiency 
in 5 minutes can be obtained with an A level range between 4 
to 5 %, and a B level range from 4-5 %. It is evident from 
contour plot that the high levels of A and high levels of B 
favors dissolution efficiency in 5 minutes of mefenamic acid 
fast dissolving tablets. The effects of A and C on dissolution 
efficiency in 5 minutes are shown in Fig 7. The contour plots 
were found to be linear indicating a linear relationship 
between A and C on dissolution efficiency in 5 minutes. It 
was determined from the contour plot (Fig. 7 B), that a 
higher dissolution efficiency in 5 minutes can be obtained 
with an A level range between 4 to 5 %, and a C level range 
from 4 – 5 %. It is evident from contour plot that the low 
levels of A and high levels of C favors dissolution efficiency in 
5 minutes of mefenamic acid fast dissolving tablets. The 
effects of B and C on dissolution efficiency in 5 minutes are 
shown in Fig 8. The contour plots were found to be linear 
indicating a linear relationship between B and C on 
dissolution efficiency in 5 minutes. It was determined from 
the contour plot (Fig. 8. B) that higher dissolution efficiency 
in 5 minutes can be obtained with a B level range between 4 
to 5 %, and a C level range from 4-5 %. It is evident from 
contour plot that the high levels of B and C favors dissolution 
efficiency in 5 minutes of mefenamic acid fast dissolving 
tablets.  
Comparison of Optimized Mefenamic acid Fast 
Dissolving Tablet (F2) with the Marketed Sample (Meftal 
250): 
The optimized formula was compared with the marketed 
formula (MEFTAL -250).  The physical properties of 
optimized mefenamic acid fast dissolving tablets (F2) and 
the marketed formulation (MEFTAL 250) were almost 
similar.
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Table 11: Physical properties: Hardness, Friability, Drug Content, Wetting Time, Water Absorption Ratio of Optimized 
Mefenamic acid Fast Dissolving Tablet (F2) employing modifies starch and Marketed Formulation (Meftal 250). 
Formul-
ation 
code 
Hardness 
(Kg/Cm2) 
±S.D 
Friability 
(%)±S.D 
Drug 
Content±S.D 
Disintegration 
Time (S)±S.D 
Wetting 
Time 
(sec)±S.D 
Water 
Absorption 
Ratio(%)±S.D 
Meftal 250 3.9±0.02 0.13±0.012 196.23±0.13 23±0.1 17±0.2 1.42±0.1 
F2 3.7±0.03 0.14±0.013 198.12±0.79 25±0.6 19±0.22 1.54±0.14 
*SD standard deviation from mean, n=3, mean±SD. 
 
Table: 12. Dissolution Data of Optimized Mefenamic acid 
Fast Dissolving Tablets Employing Modified starch (F2) 
and Marketed Formulation 
Mefenamic acid Percent Dissolved from Fast Dissolving 
Tablets  
Time (Min) Meftal 250 F2 
5 86.35±0.13 89.12±0.74 
10 96.35±0.11 99.94±0.41 
*SD standard deviation from mean, n=3, mean±SD. 
 
 
Fig. 9: Dissolution Profiles of Optimized Mefenamic acid 
Fast Dissolving Tablets Employing Modified starch and 
Marketed Formulation. (F & Meftal 250) 
 
Fig 8.10:Log Time Vs Log Percent Undissolved of 
optimized Mefenamic acid Fast Dissolving Tablets 
Employing Modified starch and marketed formulation 
(F2 & Meftal 250) 
 
Table 13: Dissolution Parameters of Optimized 
Mefenamic acid Fast Dissolving Tablets Formulated 
Employing Modified starch (F2) and Marketed 
Formulation (Meftal 250)  
Parameters Meftal 250 F2 
PD5 86.35±0.13 89.12 ± 0.74 
DE5 (%) 82.9 88.1 
K1 (min-1) 0.3316 0.3915 
*SD standard deviation from mean, n=3, mean±SD, PD5-
Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 
min., K1 =First order rate constant
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Mefenamic acid Fast Dissolving Tablets (Meftal 250) 
 
 
At T=0 sec At T=256 sec 
F2 Mefenamic acid Fast Dissolving Tablets 
 
 
Fig: 11 Wetting Times of Optimized Mefenamic acid Fast Dissolving Tablets Employing Modified starch and marketed 
formulation (F2 & Meftal 250) 
 
CONCLUSION: 
Modified starch is an efficient superdisintegrant for fast 
dissolving tablets. Drug release from the prepared tablets 
was rapid and   is with in 10min and depended on the 
composition of the tablet i.e., concentration of modified 
starch, croscarmellose sodium and crospovidone. Based on 
the results obtained from polynomial equations and 
response surface methodology, the individual effects of  
modified starch (A), croscarmellose sodium (B) and 
crospovidone (C) and interaction between ABC are more 
significant and positive effect on dissolution efficiency in 5 
minutes response surface plots and contour plots indicated 
that the   dissolution efficiency in 5 minutes of mefenamic 
acid  fast dissolving tablets is influenced mostly by modified 
satrch, followed by  croscarmellose sodium and  
crospovidone. Fast dissolving tablets (F2) formulated 
employing modified starch (5%), croscarmellose sodium 
(0%) and crospovidone (0%) exhibited rapid disintegration 
and fast release of drug within 10 minutes. 
Optimization of mefenamic acid fast dissolving tablets is a 
complex process when a new starch based 
superdisintegrant; modified starch is used as a 
superdisintegrant, which requires considering a large 
number of variables and their interactions with each other. 
The present study conclusively demonstrates the use of 23 – 
factorial design in optimization of mefenamic acid fast 
dissolving tablets. The derived polynomial equations and 
contour plots aid in predicting the values of selected 
independent variables for preparation of mefenamic acid fast 
dissolving tablets with desired properties.  
The optimized formulation (F2) gives the best result in terms 
of the required disintegration time, dissolution efficiency in 5 
minutes, and drug release was in accordance with the USP 
dissolution criteria for conventional tablet of mefenamic 
acid. It is thus concluded that by adopting systematic 
approach, an optimum point can be reached in shortest time 
with minimum efforts when modified starch, is used as a 
superdisintegrant for achieving fast dissolving formulations. 
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